Amedisys Inc - Common Stock (AMED)

Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers

BALA CYNWYD, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Amedisys, Inc. (NASDAQAMED) is one of today’s top gainers. The company’s shares are currently up 14.26% on the day to $90.8.

BALA CYNWYD, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

BALA CYNWYD, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

BALA CYNWYD, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

BALA CYNWYD, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Amedisys, Inc. (“Amedisys” or the “Company”) (Nasdaq – AMED) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Optum (“Optum”). Under the terms of the Agreement, Amedisys shareholders will only $101.00 per share in cash.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amedisys, Inc. (NASDAQAMED) to Optum for $101.00 per share is fair to Amedisys shareholders.

Amedisys Board Determines Optum Proposal Could Reasonably be Expectedto Result in a Superior Proposal

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (NasdaqGS: AMED) to Option Care Health, Inc. ("Option Care") (NasdaqGS: OPCH). Under the terms of the proposed transaction, shareholders of Amedisys will receive 3.0213 shares of Option Care for each share of Amedisys that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amedisys, Inc. (NASDAQAMED) to Option Care Health, Inc. for 3.0213 shares of Option Care common stock for each share of Amedisys common stock is fair to Amedisys shareholders.

BATON ROUGE, La., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQAMED), a leading provider of quality home health, hospice, personal care and high-acuity care, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to $100 million of its outstanding common stock through December 31, 2023.

LITTLE ROCK, Ark. and NASHVILLE, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQAMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its joint venture with the University of Arkansas for Medical Sciences (UAMS) to provide home health services in Searcy and Little Rock.

BATON ROUGE, La. and NASHVILLE, Tenn., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Amedisys is recognized as one of the most responsible companies in the nation, according to a report by Statista in the latest issue of Newsweek magazine. The recognition is based on key performance indicators derived from the company’s corporate social responsibility and sustainability report and includes performance in the areas of environment, social and corporate governance.

BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQAMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice President and Chief Financial Officer, its Acting Chief Operating Officer, effective immediately.

BATON ROUGE, La., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQAMED), a leading provider of quality home health, hospice, personal care and high-acuity care, issued the following statement following the CY 2023 Home Health Final Rule by the Centers for Medicare and Medicaid Services (CMS).

 The partnership is the first-of-its-kind in the region and creates a new care at home option for patients, including Recovery Care at Home, Rehabilitation Care at Home, Palliative Care at Home, Primary Care at Home and Home Health

Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – Over the last few years, and with the ‘help’ of the pandemic, home health care medical equipment industry has surged. Home medical equipment are medical devices that offer safe, convenient, cost-effective, and suitable environment to patients within their home. The home medical equipment […]

Henry Ford Health System announced a new partnership today with the nation’s leading operator of high-acuity home care, Contessa, an Amedisys company (NASDAQAMED). The joint venture’s high-acuity home care offering includes Hospital Care at Home, Skilled Nursing Care at Home and Palliative Care at Home, which brings all the essential elements of hospital, rehabilitation and medical care for skilled nursing patients and broader palliative care services into the comfort of patients’ homes. This first-for-Michigan at-home option is proven to decrease costs and improve outcomes for enrolled patients.

Palm Beach, FL – July 14, 2021 – The home medical equipment market has transformed within recent years, owing to increase in prevalence of various chronic diseases across the globe. Home medical equipment are medical devices that offer safe, convenient, cost-effective, and suitable environment to patients within their home. Further, oxygen-related products in home medical equipment are gaining high adoption, due to significant increase in incidence of chronic obstructive pulmonary disease (COPD) worldwide. Numerous devices are used for patient care at home, for example, infusion pumps, wheelchair, apnea monitors, glucose meters, and cannula. For instance, glucose meters or glucometers are routinely used at home to assess the level of glucose in blood for diabetics. Further, new technologies such as needle-free diabetic care, medication administration equipment, and durable medical equipment, such as medical beds and lift chairs, propel the home medical equipment market growth. However, high cost associated with these devices is anticipated to hamper the growth of home medical equipment market.   Active healthcare companies in the markets this week include Quipt Home Medical Corp. (NASDAQQIPT) (TSX-V: QIPT), AdaptHealth Corp. NASDAQ: AHCONASDAQAHCO)(NASDAQ: VMDNASDAQVMD (TSX: VMD), Amedisys, Inc. (NASDAQ: AMEDNASDAQ), Apria, Inc. (NASDAQ: APRAPR).